~~<i id='CE29DABD10'><strike id='CE29DABD10'><tt id='CE29DABD10'><pre id='CE29DABD10'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：explore 2025-09-30 18:16:45 - browse：78348

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Bristol 'take

knowledge

focus

leisure time

focus

Wikipedia

DarronCummings/APAcouplebillionhere,acouplebillionthere,andprettysoonEliLillyhopesitwillbetalkingabo

WSS

Why Charlie Gard's case is so disturbing to Americans

Why Charlie Gard's case is so disturbing to Americans

Trump used to be more articulate. What could explain the change?

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

It was time to plan for my old age. If only I could stop crying

Pennsylvania man bitten on the head by bear during attack in his garage

focus

knowledge

knowledge

Medical leaders decry Supreme Court decision on affirmative action

Many breast cancer patients receive more radiation than needed

DIEP, the 'gold standard' of breast reconstruction, is under threat

Pennsylvania man bitten on the head by bear during attack in his garage

Wildfire smoke exposes gaps in outdoor worker protections

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Slovenia has suffered its worst

Walensky prepares to leave CDC — and Congress — behind

Doctors are clamoring for more clarity on Paxlovid prescribing

focus

Why Charlie Gard's case is so disturbing to Americans

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

A virus, fished out of a lake, may have saved a man’s life

Bill would stop addiction treatment from triggering child abuse inquiry

Sana to lay off nearly a third of staff, de

FDA rejects Alnylam's heart disease treatment over insufficient data

leisure time

leisure time

focus

Wikipedia